These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7254945)

  • 1. Heparin clearance in the newborn.
    McDonald MM; Jacobson LJ; Hay WW; Hathaway WE
    Pediatr Res; 1981 Jul; 15(7):1015-8. PubMed ID: 7254945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect.
    De Stefano V; Leone G; De Carolis MP; Ferrelli R; De Carolis S; Pagano L; Tortorolo G; Bizzi B
    Thromb Haemost; 1987 Jun; 57(3):329-31. PubMed ID: 3660333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution, circulating half-life, and excretion of intravenously administered protamine sulfate.
    DeLucia A; Wakefield TW; Kadell AM; Wrobleski SK; VanDort M; Stanley JC
    ASAIO J; 1993; 39(3):M715-8. PubMed ID: 8268631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of ceftriaxone in the first three month of life].
    Rondanelli R; Regazzi MB; Stronati M; Calvi M; Lombardi G; Rondini G
    Pediatr Med Chir; 1992; 14(1):55-9. PubMed ID: 1579518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].
    Schoch U; Zanetti E; von Felten A
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1807-10. PubMed ID: 2962279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.
    de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Sixma JJ; Bouma BN
    Thromb Haemost; 1984 Aug; 52(1):66-70. PubMed ID: 6495266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of heparin. II. Studies of time dependence in rats.
    Bjornsson TD; Levy G
    J Pharmacol Exp Ther; 1979 Aug; 210(2):243-6. PubMed ID: 458631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin response and clearance in acute and chronic liver disease.
    Sette H; Hughes RD; Langley PG; Gimson AE; Williams R
    Thromb Haemost; 1985 Oct; 54(3):591-4. PubMed ID: 4089794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postheparin plasma lipoprotein and hepatic lipases in preterm neonates.
    Rovamo L; Nikkilä EA; Taskinen MR; Raivio KO
    Pediatr Res; 1984 Nov; 18(11):1104-7. PubMed ID: 6393024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sodium balance in premature infants].
    Prekajski NB; Ljujić M; Dudić S; Ranković M
    Srp Arh Celok Lek; 1998; 126(1-2):6-12. PubMed ID: 9525076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional antithrombin III in sick premature infants.
    Andrew M; Massicotte-Nolan P; Mitchell L; Cassidy K
    Pediatr Res; 1985 Feb; 19(2):237-9. PubMed ID: 3982886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin elimination in uraemic patients on Haemodialysis.
    Teien AN; Bjoornson J
    Scand J Haematol; 1976 Jul; 17(1):29-35. PubMed ID: 959771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard assays underestimate the concentration of heparin in neonatal plasma.
    Schmidt B; Mitchell L; Ofosu F; Andrew M
    J Lab Clin Med; 1988 Nov; 112(5):641-3. PubMed ID: 3183496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levels of antithrombin III and proteins C in the newborn infant].
    Abad A; Marco Vera P; Mompel A; García Pérez A
    Sangre (Barc); 1989 Apr; 34(2):91-5. PubMed ID: 2756455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic studies of antithrombin III heparin cofactor in the newborn.
    Hathaway WE; Neumann LL; Borden CA; Jacobson LJ
    Thromb Haemost; 1978 Jun; 39(3):624-30. PubMed ID: 705691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin elimination in patients with liver cirrhosis.
    Teien AN
    Thromb Haemost; 1977 Oct; 38(3):701-6. PubMed ID: 579516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
    Jun L; Arnout J; Vanhove P; Dol F; Lormeau JC; Herbert JM; Collen D; Van de Werf F
    Coron Artery Dis; 1995 Mar; 6(3):257-63. PubMed ID: 7788040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.